MicroRNA-552 expression in colorectal cancer and its clinicopathological significance
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: MicroRNA-552 (miR-552) has been reported to correlate with the development and progression of various cancers, including colorectal cancer (CRC). This study aimed to investigate miR-552 expression in cancer tissue samples compared to normal mucosal tissue and its role as a diagnostic or prognostic marker in CRC patients. Methods: Normal mucosal tissues and primary cancer tissues from 80 surgically resected CRC specimens were used. Quantitative real-time polymerase chain reaction was performed for miR-552 and U6 small nuclear RNA to analyze miR-552 expression and its clinicopathological significance. Immunohistochemistry for p53 and phosphatase and tension homolog (PTEN) was performed to evaluate their association with miR-552 expression. Results: miR-552 expression was significantly higher in primary cancer tissues compared to normal mucosal tissues (p < .001). The expression level of miR-552 was inversely correlated with that of PTEN (p = .068) and p53 (p = .004). Survival analysis showed that high miR-552 expression was associated with worse prognosis but this was not statistically significant (p = .255). However, patients with CRC having high miR-552 expression and loss of PTEN expression had significantly worse prognosis than others (p =. 029). Conclusions: Our results suggest that high miR-552 expression might be a potential diagnostic biomarker for CRC, and its combined analysis with PTEN expression can possibly be used as a prognostic marker.
Abstract
Background: MicroRNA-552 (miR-552) has been reported to correlate with the development and progression of various cancers, including colorectal cancer (CRC). This study aimed to investigate miR-552 expression in cancer tissue samples compared to normal mucosal tissue and its role as a diagnostic or prognostic marker in CRC patients. Methods: Normal mucosal tissues and primary cancer tissues from 80 surgically resected CRC specimens were used. Quantitative real-time polymerase chain reaction was performed for miR-552 and U6 small nuclear RNA to analyze miR-552 expression and its clinicopathological significance. Immunohistochemistry for p53 and phosphatase and tension homolog (PTEN) was performed to evaluate their association with miR-552 expression. Results: miR-552 expression was significantly higher in primary cancer tissues compared to normal mucosal tissues (p < .001). The expression level of miR-552 was inversely correlated with that of PTEN (p = .068) and p53 (p = .004). Survival analysis showed that high miR-552 expression was associated with worse prognosis but this was not statistically significant (p = .255). However, patients with CRC having high miR-552 expression and loss of PTEN expression had significantly worse prognosis than others (p =. 029). Conclusions: Our results suggest that high miR-552 expression might be a potential diagnostic biomarker for CRC, and its combined analysis with PTEN expression can possibly be used as a prognostic marker.
참고문헌 (42)
- Bray F, "Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J Clin, 68, pp.394~424 (2018)
- 홍세리, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017", Cancer Research and Treatment, 52(2), pp.335~350 (2020), 대한암학회
- Markowitz SD, "Molecular origins of cancer : Molecular basis of colorectal cancer", N Engl J Med, 361, pp.2449~2460 (2009)
- Luo X, "MicroRNA signatures : novel biomarker for colorectal cancer?", Cancer Epidemiol Biomarkers Prev, 20, pp.1272~1286 (2011)
- Koga Y, "MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening", Cancer Prev Res(Phila), 3, pp.1435~1442 (2010)
- Krek A, "Combinatorial microRNA target predictions", Nat Genet, 37, pp.495~500 (2005)
- Lee RC, "The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14", Cell, 75, pp.843~854 (1993)
- Bartel DP, "MicroRNAs : genomics, biogenesis, mechanism, and function", Cell, 116, pp.281~297 (2004)
- Jeffrey SS, "Cancer biomarker profiling with microRNAs", Nat Biotechnol, 26, pp.400~401 (2008)
- Calin GA, "Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers", Proc Natl Acad Sci U S A, 101, pp.2999~3004 (2004)
- Ji J, "Wnt", beta-catenin signaling activates microRNA-181 expression in hepatocellular carcinoma, 2011, pp.1, 4~
- Kim NH, "p53 and microRNA-34 are suppressors of canonical Wnt signaling", Sci Signal, 4, pp.ra71~ (2011)
- Cai J, "MicroRNA-374a activates Wnt", betacatenin signaling to promote breast cancer metastasis, 2013, pp.123, 566~579
- Calin GA, "MicroRNA signatures in human cancers", Nat Rev Cancer, 6, pp.857~866 (2006)
- Lu J, "MicroRNA expression profiles classify human cancers", Nature, 435, pp.834~838 (2005)
- Volinia S, "A microRNA expression signature of human solid tumors defines cancer gene targets", Proc Natl Acad Sci U S A, 103, pp.2257~2261 (2006)
- Calin GA, "MicroRNA-cancer connection : the beginning of a new tale", Cancer Res, 66, pp.7390~7394 (2006)
- Hayes J, "MicroRNAs in cancer : biomarkers, functions and therapy", Trends Mol Med, 20, pp.460~469 (2014)
- Wang N, "Increased expression of miR-552 acts as a potential predictor biomarker for poor prognosis of colorectal cancer", Eur Rev Med Pharmacol Sci, 22, pp.412~416 (2018)
- Xia ZS, "MiR-5000-3p, miR-5009-3P and miR-552 : potential microRNA biomarkers of side population cells in colon cancer", Oncol Rep, 32, pp.589~596 (2014)
- Oberg AL, "miRNA expression in colon polyps provides evidence for a multihit model of colon cancer", PLoS One, 6, pp.e20465~ (2011)
- Kwak B, "MicroRNA-552links Wnt signaling to p53 tumor suppressor in colorectal cancer", Int J Oncol, 53, pp.1800~1808 (2018)
- Cao J, "MicroRNA-552 promotes tumor cell proliferation and migration by directly targeting DACH1 via the Wnt", beta-catenin signaling pathway in colorectal cancer, 2017, pp.14, 3795~3802
- Zhao W, "miR-552 promotes ovarian cancer progression by regulating PTEN pathway", J Ovarian Res, 12, pp.121~ (2019)
- Nagtegaal ID, "The 2019 WHO classification of tumours of the digestive system", Histopathology, 76, pp.182~188 (2020)
- Weiser MR, "AJCC 8th Edition : Colorectal Cancer", Ann Surg Oncol, 25, pp.1454~1455 (2018)
- Schmittgen TD, "Analyzing real-time PCR data by the comparative C(T)method", Nat Protoc, 3, pp.1101~1108 (2008)
- 황혜정, "Prediction of TP53 mutations by p53 immunohistochemistry and their prognostic significance in gastric cancer", Journal of Pathology and Translational Medicine, 54(5), pp.378~386 (2020), 대한병리학회[DOI]
- Tong F, "MicroRNA-466(miR-466)functions as a tumor suppressor and prognostic factor in colorectal cancer(CRC)", Bosn J Basic Med Sci, 18, pp.252~259 (2018)
- Kim HK, "miR-592 and miR-552 can distinguish between primary lung adenocarcinoma and colorectal cancer metastases in the lung", Anticancer Res, 34, pp.2297~2302 (2014)
- Qu W, "MiR-552 promotes the proliferation, migration and EMT of hepatocellular carcinoma cells by inhibiting AJAP1 expression", J Cell Mol Med, 23, pp.1541~1552 (2019)
- Chen T, "Linc00261 inhibits metastasis and the WNT signaling pathway of pancreatic cancer by regulating a miR-5525p", FOXO3 axis, 2020, pp.43, 930~942
- Li C, "MicroRNA-552 promotes hepatocellular carcinoma progression by downregulating WIF1", Int J Mol Med, 42, pp.3309~3317 (2018)
- Maehama T, "The tumor suppressor, PTEN", MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3, 4, 5-trisphosphate, 1998, pp.273, 13375~13378
- Xiong B, "MiR-21 regulates biological behavior through the PTEN", PI-3 K, Int J Oncol, pp.2013, 42[DOI]
- Vivanco I, "The phosphatidylinositol 3-Kinase AKT pathway in human cancer", Nat Rev Cancer, 2, pp.489~501 (2002)
- Brandmaier A, "Cell cycle control by PTEN", J Mol Biol, 429, pp.2265~2277 (2017)
- Miyashita T, "Tumor suppressor p53 is a direct transcriptional activator of the human bax gene", Cell, 80, pp.293~299 (1995)
- Somasundaram K, "Tumor suppressor p53: regulation and function", Front Biosci., 5, pp.D424~D437 (2000)
- Han T, "miR-552 regulates liver tumor-initiating cell expansion and sorafenib resistance", Mol Ther Nucleic Acids, 19, pp.1073~1085 (2020)
- Xuehan Bi, "METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K", Akt, Cancer Gene Therapy, pp.2021, 28(3-4)[DOI]
- Kyu Sang Lee, "Stromal Expression of MicroRNA-21 in Advanced Colorectal Cancer Patients with Distant Metastases", Journal of Pathology and Translational Medicine, 50(4), pp.270~277 (2016), 대한병리학회[DOI]
